Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Depomed CEO, Two Board Members Out In Settlement With Investor

Mar 29 2017

• By Mandy Jackson

chess

Related Content

Cerulean Shifts From Ovarian Cancer To Contraceptives In Reverse Merger With Daré

Mar 24 2017

Depomed Makes Last Ditch Plea To Shareholders

Sep 15 2015

Depomed Slapped By Shareholder Discontent

Apr 09 2016

Horizon Seeks Other Deals As Depomed Thwarts Takeover

Nov 20 2015

Related Companies

Assertio Holdings, Inc.

Bayer AG

Enzon Pharmaceuticals, Inc.

Horizon Therapeutics plc

Abbott

Barr Pharmaceuticals

Agile Therapeutics, Inc.

Cerulean Pharma Inc.

Pfizer Inc.

Johnson & Johnson

Bristol Myers Squibb Company

Additional Topics

Commercial Companies Leadership Business Strategies BioPharmaceutical

More from Business

More from Scrip

Twitter feed RSS feed RSS feed

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window

Copyright © 2025 Pharma Intelligence UK Limited (Citeline), a Norstella company Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered.